Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ulrike Fritsche-Friedland"'
Autor:
Anita Badbaran, Ulrike Fritsche-Friedland, Nicolaus Kröger, Ulrike Bacher, Francis Ayuk, Evgeny Klyuchnikov, Dietlinde Janson, Christine Wolschke, Radwan Massoud
Publikováno v:
Transplantation and Cellular Therapy. 27:841-850
Minimal/measurable residual disease (MRD) before allogeneic stem cell transplantation (allo-SCT) in patients with acute myelogenous leukemia (AML) is a poor risk factor for outcome. γδ T cells represent a unique minority lymphocyte population that
Autor:
Ameya Shrinivas Kunte, Nico Gagelmann, Anita Badbaran, Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov, Christine Wolschke, Dietlinde Janson, Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger, Francis A. Ayuk
Publikováno v:
Blood. 140:7531-7532
Autor:
Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, Ulrike Fritsche-Friedland, Dietlinde Janson, Francis Ayuk, Maximilian Christopeit, Christine Wolschke, Ulrike Bacher, Nicolaus Kröger
BACKGROUND Patients with relapsed/refractory AML have a dismal prognosis. Allogeneic stem cell transplantation (allo-SCT) provides a curative approach, however the overall survival (OS) remains low (20-40%). In this setting, though some effective app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9365e0a85b5ae598f179872597c8276
Autor:
Radwan Massoud, Nico Gagelmann, Nicolaus Kröger, Wolschke Christine, Tatjana Zabelina, Evgeny Klyuchnikov, Axel R. Zander, Francis Ayuk, Ulrike Fritsche-Friedland
Publikováno v:
Blood. 138:3897-3897
Introduction: Data on the influence of different ATLG doses on immune reconstitution (IR) and GvHD in MUD allo-SCT is limited. In this study, we compared the impact of ATLG doses (30mg/kg vs 60 mg/kg) on IR and transplant outcomes. Methods: In this r
Autor:
Ulrike Fritsche-Friedland, Francis Ayuk, Radwan Massoud, Anita Badbaran, Christine Wolschke, Nicolaus Kröger, Dietlinde Janson, Maximilian Christopeit, Evgeny Klyuchnikov
Publikováno v:
Blood. 138:4909-4909
Introduction Patients with relapsed/refractory (r/r) AML have in general a dismal prognosis. Allogeneic stem cell transplantation (allo-SCT) provides a curative approach for these patients, however the overall survival (OS) remains still low achievin
Autor:
Axel R. Zander, Michael Lioznov, N. Kroeger, Francis Ayuk, Thomas Stuebig, Ulrike Bacher, Christine Wolschke, Haefaa Alchalby, Ulrike Fritsche-Friedland
Publikováno v:
Blood. 118:4555-4555
Abstract 4555 Introduction: Activating and inhibitory killer immunoglobulin like receptors (KIR) are predominantly expressed on natural killer (NK) cells. KIR mismatch allogeneic stem cell transplantation (alloSCT) has been reported to provide benefi
Autor:
Ulrike Fritsche-Friedland, Ulrike Bacher, Haefaa Alchalby, Axel R. Zander, Thomas St big, Michael Lioznov, Francis Ayuk, Christine Wolschke, Nicolaus Kröger
Publikováno v:
Blood. 116:4689-4689
Abstract 4689 Introduction: Allogenic stem cell transplantation (allo SCT) offers a potential curative approach for many malignant and non malignant haematological diseases. Despite its therapeutic benefit, long term immunodeficiency, poor immune rec